Generics giant Mylan completes Meda deal

9 August 2016 - Deborah Wilkes

Archived

Generics giant Mylan has completed the acquisition of Sweden's Meda. President Rajiv Malik said acquiring Meda opened up a number of new opportunities for Mylan, such as "significantly expanding our OTC presence into a US$1 billion business".

Click tags below for more information on topics:

Mylan

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: